Erik Harris

Companies

• Rezolute, Inc.Board member Mar 26, 2025 to now¹
• Inozyme Pharma, Inc.Board member Oct 7, 2024 to now²
• Ultragenyx Pharmaceutical Inc.EVP & Chief Commercial Officer Jun 21, 2019 to now³
• Denali Therapeutics Inc.Board member Feb 7, 2022 to Jun 4, 2024⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• UPUltragenyx Pharmaceutical Inc. RARE118,410 shares⁵$1.8M at $14.96Apr 16, 2026
• DTDenali Therapeutics Inc. DNLI17,052 shares⁶$311.2K at $18.25May 31, 2024
• RRezolute, Inc. RZLT21,000 shares⁷$77.6K at $3.69Nov 19, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Apr 16, 2026Granted 28,895 shares of Ultragenyx Pharmaceutical Inc.⁵
• Mar 2, 2026Sold 10,539 shares at $22.80 of Ultragenyx Pharmaceutical Inc.⁸
• Mar 1, 2026Granted 11,643 shares of Ultragenyx Pharmaceutical Inc.⁸
• Nov 19, 2025Granted 21,000 shares of Rezolute, Inc.⁷
• Mar 3, 2025Sold 15,103 shares at $42.10 of Ultragenyx Pharmaceutical Inc.⁹
• Mar 1, 2025Granted 18,443 shares of Ultragenyx Pharmaceutical Inc.⁹
• Mar 1, 2025Granted 16,813 shares of Ultragenyx Pharmaceutical Inc.⁹
• May 31, 2024Granted 5,967 shares of Denali Therapeutics Inc.⁶
• Mar 1, 2024Sold 4,768 shares at $53.76 of Ultragenyx Pharmaceutical Inc.¹⁰
• Mar 1, 2024Granted 957 shares of Ultragenyx Pharmaceutical Inc.¹⁰
• Mar 1, 2024Granted 19,400 shares of Ultragenyx Pharmaceutical Inc.¹⁰
• Sep 5, 2023Sold 6,000 shares at $37.96 of Ultragenyx Pharmaceutical Inc.¹¹
• Jun 19, 2023Sold 305 shares at $48.20 of Ultragenyx Pharmaceutical Inc.¹²
• Jun 1, 2023Granted 4,216 shares of Denali Therapeutics Inc.¹³
• Mar 1, 2023Sold 3,664 shares at $45.25 of Ultragenyx Pharmaceutical Inc.¹⁴
• Mar 1, 2023Granted 22,000 shares of Ultragenyx Pharmaceutical Inc.¹⁴
• Mar 1, 2023Granted 2,663 shares of Ultragenyx Pharmaceutical Inc.¹⁴
• Jun 19, 2022Sold 295 shares at $54.78 of Ultragenyx Pharmaceutical Inc.¹⁵
• Mar 1, 2022Granted 14,000 shares of Ultragenyx Pharmaceutical Inc.¹⁶
• Mar 1, 2022Sold 2,713 shares at $66.62 of Ultragenyx Pharmaceutical Inc.¹⁶
• Feb 3, 2022Granted 6,869 shares of Denali Therapeutics Inc.¹⁷
• Oct 14, 2021Sold 303 shares at $81.14 of Ultragenyx Pharmaceutical Inc.¹⁸